Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine

Mengyu Guo; Mingjing Cao; Jiufeng Sun; Ziwei Chen; Xin Wang; Lianpan Dai; George F. Gao; Yuliang Zhao; Yaling Wang; Chunying Chen

doi:10.1038/s41392-023-01718-8

Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine

Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George F. Gao, Yuliang Zhao, Yaling Wang, Chunying Chen

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Article number	462
Journal	Signal Transduction and Targeted Therapy
Volume	8
Issue number	1
DOIs	https://doi.org/10.1038/s41392-023-01718-8
State	Published - Dec 2023

ASJC Scopus subject areas

Genetics
Cancer Research

Access to Document

10.1038/s41392-023-01718-8

Cite this

@article{de572b8aa7e94218915e657b2ef847f3,

title = "Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine",

author = "Mengyu Guo and Mingjing Cao and Jiufeng Sun and Ziwei Chen and Xin Wang and Lianpan Dai and Gao, {George F.} and Yuliang Zhao and Yaling Wang and Chunying Chen",

note = "Funding Information: This work was supported by the National Basic Research Program of China (2022YFA1603701 and 2021YFA1200900), the National Natural Science Foundation of China (82341044, 22027810), the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science (CIFMS 2019-I2M-5-018), Strategic Priority Research Program of the Chinese Academy of Sciences (XDB36000000), and the China Postdoctoral Science Foundation (2021TQ0085, 2022M720932). We thank Xuemei Zhou and Yaling An from the Institute of Microbiology for their help in the preparation of RBD dimer antigen. And we thank Xi Chen and Wenjiao Fu from the National Center for Nanoscience and Technology, who helped with the animal experiments. Funding Information: This work was supported by the National Basic Research Program of China (2022YFA1603701 and 2021YFA1200900), the National Natural Science Foundation of China (82341044, 22027810), the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science (CIFMS 2019-I2M-5-018), Strategic Priority Research Program of the Chinese Academy of Sciences (XDB36000000), and the China Postdoctoral Science Foundation (2021TQ0085, 2022M720932). We thank Xuemei Zhou and Yaling An from the Institute of Microbiology for their help in the preparation of RBD dimer antigen. And we thank Xi Chen and Wenjiao Fu from the National Center for Nanoscience and Technology, who helped with the animal experiments.",

year = "2023",

month = dec,

doi = "10.1038/s41392-023-01718-8",

language = "English (US)",

volume = "8",

journal = "Signal Transduction and Targeted Therapy",

issn = "2095-9907",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine

AU - Guo, Mengyu

AU - Cao, Mingjing

AU - Sun, Jiufeng

AU - Chen, Ziwei

AU - Wang, Xin

AU - Dai, Lianpan

AU - Gao, George F.

AU - Zhao, Yuliang

AU - Wang, Yaling

AU - Chen, Chunying

N1 - Funding Information: This work was supported by the National Basic Research Program of China (2022YFA1603701 and 2021YFA1200900), the National Natural Science Foundation of China (82341044, 22027810), the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science (CIFMS 2019-I2M-5-018), Strategic Priority Research Program of the Chinese Academy of Sciences (XDB36000000), and the China Postdoctoral Science Foundation (2021TQ0085, 2022M720932). We thank Xuemei Zhou and Yaling An from the Institute of Microbiology for their help in the preparation of RBD dimer antigen. And we thank Xi Chen and Wenjiao Fu from the National Center for Nanoscience and Technology, who helped with the animal experiments. Funding Information: This work was supported by the National Basic Research Program of China (2022YFA1603701 and 2021YFA1200900), the National Natural Science Foundation of China (82341044, 22027810), the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science (CIFMS 2019-I2M-5-018), Strategic Priority Research Program of the Chinese Academy of Sciences (XDB36000000), and the China Postdoctoral Science Foundation (2021TQ0085, 2022M720932). We thank Xuemei Zhou and Yaling An from the Institute of Microbiology for their help in the preparation of RBD dimer antigen. And we thank Xi Chen and Wenjiao Fu from the National Center for Nanoscience and Technology, who helped with the animal experiments.

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85179883584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85179883584&partnerID=8YFLogxK

U2 - 10.1038/s41392-023-01718-8

DO - 10.1038/s41392-023-01718-8

M3 - Letter

C2 - 38104162

AN - SCOPUS:85179883584

SN - 2095-9907

VL - 8

JO - Signal Transduction and Targeted Therapy

JF - Signal Transduction and Targeted Therapy

IS - 1

M1 - 462

ER -

Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this